ESH Video

ESH-Eurocord-Eurocord-Ed Netcord WORLD CORD BLOOD CONGRESS

ESH-Eurocord-Eurocord-Ed Netcord WORLD CORD BLOOD CONGRESS
November 04 - November 07, 2010 - Marseille, France
Chairs :


The upcoming WORLD CORD BLOOD CONGRESS will cover a wide range of topics including cord blood transplant in adults and children, the role of HLA in cord blood transplant, stem cells, cord blood banking and regulatory issues. A international panel of distinguished scientists and clinicians will participate in this major international forum over three days of interactive conferencing. The scientific programme will comprise a series of plenary presentations and debates. Poster sessions and short oral communications selected from submitted abstracts will enable registered participants to present their own data.

The WORLD CORD BLOOD CONGRESS is open to all the professional actors working in the fields related to cord blood biology and clinical applications, from both the public and private sectors, including physicians, research scientists, technicians, data analysts and nurses. The congress will also be of interest to healthcare policy decision makers.


Thursday, November 4, 2010

12h00 Registration Opens

Session I: Stem Cells from Cord Blood and Placenta - Chair: C. Chabannon

14h00 - 14h30 Cord blood stem cell biology and means to enhance hematopoietic stem cell function for more efficient engrafting capability H.E. Broxmeyer (Indianapolis)
14h30 - 15h00 iPS from cord blood J.C. Ispizua-Belmonte
(San Diego)
15h00 - 15h30 Production of USSC from cord blood and possible clinical developments G. Koegler (Dusseldorf)
15h30 - 16h00 The role of Notch in haematopoiesis basic biology and clinical implications I. Bernstein (Seattle)
16h00 - 16h20 Notch induced ex vivo expansion of hematopoietic stem/progenitor cells clinical applications updates C. Delaney (Seattle)
16h20 - 16h45 Coffee break

Session II: Non hematopoietic stem cells from cord blood and placenta - Chair: H.E. Broxmeyer

16h45 - 17h10 The role of INFg for neurological differentiation from HUCB A. Nagler (Tel Hashomer)
17h10 - 17h35 Endothelial cells isolation from cord blood for treatment of vascular diseases G. Uzan (Paris)
17h35 - 18h00 Cord blood endothelial progenitors: perspectives for cell therapy of cardiovascular disorders F. Dignat - George (Marseille)
18h00 - 18h25 Placental perfusion experiments: what is it? What else? F. Forestier (Paris)
18h25 - 18h45 Hematopoietic and muscular potencial of amiotic fluid derived stem cells I Andre-Schmutz (Paris)
19h00 - 20h30 Opening Ceremony

Friday, November 5, 2010

Session III: Clinical applications in non hematopoietic diseases - Chair: E.J. Shpall

08h30 - 09h00 Status of a clinical trial of autologous cord blood cells for the treatment of cerebral palsy and other acquired brain injuries J. Kurtzberg (Durham)
09h00 - 09h30 Application of stem cells in the treatment of epidermolysis bullosa J. Wagner (Minneapolis)
09h30 - 10h00 Cell therapy of burns J.J. Lataillade (Clamart)
10h00 - 10h30

Coffee break

Session IVa: Graft facilitation - Chair: W. Arcese

10h30 - 11h00 Stem cell regulation by bFGF, kit ligand and myeloid cells T. Lapidot (Rehovot)
11h00 - 11h30 PGE for graft facilitation L. Pelus (Indianapolis)
11h30 - 12h00 Enhanced engraftment with cord blood expansion and fucolysation E.J. Shpall (Houston)
12h00- 12h30 Intrabone infusion of cord blood cells F. Frassoni (Genova)
12h30 - 13h00 Use of third party cells to facilitate engraftment M.N. Fernandez (Madrid)
13h00 - 14h00

Lunch and Poster Viewing

Session IVb: Graft facilitation - Chair: J. Kurtzberg
14h00 - 14h30 Results of double cord blood transplant V. Rocha (Paris)
14h30 - 15h00 Mechanism of graft facilitation with double cord transplant J. Wagner (Minneapolis)
15h00 - 15h30 Should the number of collected CD34+ cells be considered major criteria for UCB unit choice in adults? G. Sanz (Valencia)
15h30 - 16h00 Role of HLA in cord blood transplant E. Petersdorf (Seattle)
16h00 - 16h30 Coffee break

Session V: Immunological properties of cord blood - Chair: F. Locatelli

16h30 - 17h00 Potential immunotherapeutic properties of cord blood A. Madrigal (London)
17h00 - 17h30 Virus and tumour specific cord blood T cells C. Bollard (Houston)
17h30 - 18h00 Use of cord blood cells for anti tumour and anti infectious immunotherapy F. Falkenburg (Leiden)
18h00 - 18h20 Comparison between MSC derived from bone marrow and cord blood M.E. Bernardo (Rome)

Saturday, November 6, 2010

Session VI: Clinical results I - Chair: G. Michel
09h00 - 09h30 Comparison of haploidentical and cord blood in children with immune deficiencies M. Cavazzana-Calvo (Paris)
09h30 - 10h00 Impact of stem cell source for transplant in adults with leukemia M. Eapen (Milwaukee)
10h00 - 10h20 Comparison of cord blood transplants with other sources of cells in Hurler disease J. Boelens (Utrecht)
10h20- 10h45 Coffee break
10h45 - 11h10 Reduced intensity conditioning French results B. Rio (Paris)
11h10 - 11h35 Non T-cell G-CSF primed haploidentical bone marrow transplant in patients with high risk hematological malignancies W. Arcese (Rome)
11h35 - 12h00 Single cord blood transplantation followed by myeloablative regimen for adults - Recent progress in Japan S. Takahashi (Tokyo)
12h00 - 12h25 Incidence and risk factors for secondary autoimmune diseases after CBT D. Farge (Paris)
12h30 - 14h00

Lunch and poster viewing

Session VII: Related cord blood transplants - Chair: G. Sanz
14h00 - 14h30 Related cord blood transplant in hemoglobinopathies F. Locatelli (Rome)
14h30 - 15h00 Gene therapy for hemoglobinopathies M. Cavazzana-Calvo (Paris)
15h00 - 15h30 Directed cord blood banking E. Gluckman (Paris)
15h30 - 15h45 Ethical aspects P. Le Coz (Marseille)
15h45 - 16h30 Round table: family cord blood banking
16h30 - 17h00 Coffee break
Session VIII: CLINICAL RESULTS II - Chair: V. Rocha
17h00 - 17h20 Results of unrelated cord blood transplant in children with malignant malignancies G. Michel (Marseille)
17h20 - 17h40 Results of unrelated cord blood transplant in children with lymphoid malignancies A.L. Ruggeri (Paris)
17h40 - 18h00 Incidence and risk factors of chronic GVH after unrelated cord blood transplant in adults and children A. Crotta (Milan)
18h00 - 18h30 Presentation of selected abstracts

Sunday, November 7, 2010

Session IX: Regulatory organisational ethical aspects - Chair: E. Baudoux

08h30 - 08h50 Netcord organisation E. Baudoux (Liège)
08h50 - 09h15 Optimising cord blood inventories S. Querol (Barcelona)
09h15 - 09h40 Advanced medicinal products and cord blood banking C. Chabannon (Marseille)
09h40 - 09h50

Predictivity of Cord Blood Units Quality
Assessments on Unrelated Cord Blood Transplant outcome

A. Picardi (Rome)
09h50 -10h05 FACT Ph. Warkentin (Omaha)
10h05 - 10h20 FACT Netcord and WMDA accreditation C. Navarette (London)
10h20- 10h50 Coffee break
10h50 - 11h05 Implication of licensure on international exchange of cord blood units M. Boo (Minneapolis)
11h05 - 11h20 Socio economic aspects P. Rebulla (Milan)
11h20 - 11h35 Eurocord Registry V. Rocha (Paris)
11h35 - 11h50 CIBMTR Registry M. Horowitz (Milwaukee)
Closure of meeting

Abstract submission




Pullman Marseille Palm Beach
200 Corniche J.F. Kennedy
13007 Marseille

Corporate partners